Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Prodesfarma presents cardiovascular candidate

Oct. 4, 1996

Cardiovascular R&D at Takeda

Sep. 27, 1996

New treatment for peripheral vascular diseases cleared for clinical trials in the U.K.

Sep. 27, 1996

Yamanouchi launches treatment for heart failure

Sep. 27, 1996

Japanese and Korean researchers report improved antiarrhythmic agents

Sep. 27, 1996

Hoechst investigates Na+/H+-exchange inhibitors

Sep. 27, 1996

Hoechst claims new antiarrhythmic agents

Sep. 27, 1996

Cypros seeks broad international patent coverage for CPC-111

Sep. 27, 1996

Tyrosine kinase inhibitors from Warner-Lambert

Sep. 27, 1996

Bayer investigates agents for arteriosclerosis, restenosis

Sep. 27, 1996

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...